Oncologic standards in colon cancer resection: from margins to lymph node yield and mesentery

Oncologic quality in colon cancer surgery hinges on achieving adequate longitudinal margins, lymphadenectomy, and mesenteric excision, yet international standards and segment-specific practices remain heterogeneous.

A focused PubMed/MEDLINE search from inception to October 2025 identified international guidelines, randomized and non-randomized comparative studies, large registries, and meta-analyses addressing: (1) longitudinal resection margins; (2) lymph node (LN) yield and nodal metrics; and (3) complete mesocolic excision (CME) with central vascular ligation (CVL)/D3 versus standard colectomy in curative-intent colon cancer surgery. The study aimed to delineate current standards in colon cancer resection.

Mapping studies and guidelines converge on 5-7 cm longitudinal margins for most tumors, with extension toward 10 cm in advanced T stage (cT3-cT4 disease) or when arterial geometry indicates a longer at-risk pericolic segment. LN assessment beyond the historical ≥12 minimum improves staging accuracy and survival, with several large datasets suggesting a plateau around 18-22 examined nodes. CME/CVL/D3 reliably increases nodal yield and specimen quality without excess morbidity in optimized settings and appears to confer an oncologic advantage across stages II-III, with the most consistent survival signal in stage III disease.

An oncologically adequate colectomy should aim for: (1) R0 resection with 5-7 cm margins, extendable toward 10 cm when dictated by tumor stage or vascular anatomy; (2) mesenteric resection to the feeding-vessel origin targeting 18-22 LNs (minimum ≥12), with systematic reporting of tumor deposits and LN ratio; and (3) thoughtful use of CME/CVL/D3 embedded within structured training and routine audit of outcomes, particularly for stage III right colon cancers.